Clene Inc. (CLNN)
NASDAQ: CLNN · Real-Time Price · USD
5.49
+0.13 (2.52%)
At close: Mar 9, 2026, 4:00 PM EDT
5.54
+0.05 (0.91%)
After-hours: Mar 9, 2026, 4:24 PM EDT
Clene Revenue
Clene had revenue of $15.00K in the quarter ending September 30, 2025, a decrease of -82.76%. This brings the company's revenue in the last twelve months to $214.00K, down -49.17% year-over-year. In the year 2024, Clene had annual revenue of $342.00K, down -47.71%.
Revenue (ttm)
$214.00K
Revenue Growth
-49.17%
P/S Ratio
291.23
Revenue / Employee
$2,816
Employees
76
Market Cap
64.66M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| The Hain Celestial Group | 1.51B |
| Farmer Bros. Co. | 337.72M |
| Bridgford Foods | 233.75M |
| Above Food Ingredients | 213.45M |
| LifeVantage | 210.05M |
| FitLife Brands | 70.56M |
| DDC Enterprise | 36.62M |
| BioHarvest Sciences | 32.72M |
CLNN News
- 13 days ago - Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8® 2026 Catalysts - GlobeNewsWire
- 18 days ago - Clene to Present at the Emerging Growth Conference - GlobeNewsWire
- 2 months ago - Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting - GlobeNewsWire
- 2 months ago - Clene Announces Registered Direct Offering of Over $28 Million - GlobeNewsWire
- 3 months ago - Clene Announces Statistically Significant ALS Biomarker Results Supporting Accelerated Approval Pathway for CNM-Au8® - GlobeNewsWire
- 3 months ago - Clene to Provide CNM-Au8® ALS Program Update - GlobeNewsWire
- 3 months ago - Clene to Participate at the Benchmark 14th Annual Discovery One-on-One Investor Conference - GlobeNewsWire
- 4 months ago - Clene Reports Third Quarter 2025 Financial Results and Recent Operating Highlights - GlobeNewsWire